HK1142631A1 - Anti-tumor drug, medicament, composition, and use thereof - Google Patents

Anti-tumor drug, medicament, composition, and use thereof

Info

Publication number
HK1142631A1
HK1142631A1 HK10109169.4A HK10109169A HK1142631A1 HK 1142631 A1 HK1142631 A1 HK 1142631A1 HK 10109169 A HK10109169 A HK 10109169A HK 1142631 A1 HK1142631 A1 HK 1142631A1
Authority
HK
Hong Kong
Prior art keywords
medicament
composition
tumor drug
tumor
drug
Prior art date
Application number
HK10109169.4A
Other languages
English (en)
Inventor
Salman Al Mahmood
Sylvie Colin
Original Assignee
Gene Signal Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20070108349 external-priority patent/EP1992694A1/en
Priority claimed from US11/798,685 external-priority patent/US7906621B2/en
Application filed by Gene Signal Int Sa filed Critical Gene Signal Int Sa
Publication of HK1142631A1 publication Critical patent/HK1142631A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10109169.4A 2007-05-16 2010-09-24 Anti-tumor drug, medicament, composition, and use thereof HK1142631A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20070108349 EP1992694A1 (en) 2007-05-16 2007-05-16 Anti-tumor drug, medicament, composition, and use thereof
US11/798,685 US7906621B2 (en) 2007-05-16 2007-05-16 Anti-tumor drug, medicament, composition, and use thereof
PCT/EP2008/056075 WO2008138994A1 (en) 2007-05-16 2008-05-16 Anti-tumor drug, medicament, composition, and use thereof

Publications (1)

Publication Number Publication Date
HK1142631A1 true HK1142631A1 (en) 2010-12-10

Family

ID=39734168

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10109169.4A HK1142631A1 (en) 2007-05-16 2010-09-24 Anti-tumor drug, medicament, composition, and use thereof

Country Status (9)

Country Link
US (2) US8742067B2 (ja)
EP (1) EP2158317B1 (ja)
JP (1) JP5597534B2 (ja)
CN (1) CN101688205B (ja)
AU (1) AU2008249961B2 (ja)
CA (1) CA2685551C (ja)
ES (1) ES2674710T3 (ja)
HK (1) HK1142631A1 (ja)
WO (1) WO2008138994A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2907823A1 (en) * 2014-02-14 2015-08-19 Gene Signal International SA Polypeptide fragments of 168A-T2 and compositions comprising them for use in treating cancer
US9539305B1 (en) 2014-03-14 2017-01-10 Fleurir Abx Llc Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747660A (en) 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
JP2001504341A (ja) 1996-11-15 2001-04-03 セダーズ―シナイ メディカル センター シュワノミン結合タンパク質をコードする核酸およびそれに関連する産物
JP2002510974A (ja) 1997-06-27 2002-04-09 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｎｋ−３関連前立腺特異的遺伝子−１
US7034132B2 (en) * 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
FR2798674B1 (fr) 1999-09-21 2004-01-30 Mahmood Salman Al Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques
AU2001241541A1 (en) 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
US7092985B2 (en) * 2000-03-30 2006-08-15 United Devices, Inc. Method of managing workloads and associated distributed processing system
WO2001090304A2 (en) * 2000-05-19 2001-11-29 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
CA2427085A1 (en) 2000-10-27 2002-05-02 Incyte Genomics, Inc. Transmembrane proteins
US20020137081A1 (en) 2001-01-08 2002-09-26 Olga Bandman Genes differentially expressed in vascular tissue activation
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
EP1401858A4 (en) 2001-06-04 2005-12-21 Curagen Corp THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS COATING THEREOF AND METHOD OF USE
US7803915B2 (en) * 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
WO2003000113A2 (en) * 2001-06-20 2003-01-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
FR2836687A1 (fr) 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
US7803906B2 (en) * 2002-03-22 2010-09-28 Gene Signal International Sa Composition comprising an angiogenesis related protein
FR2837391B1 (fr) 2002-03-22 2007-04-20 Gene Signal Genes regulateurs de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
AU2003279084A1 (en) 2002-09-25 2004-04-19 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
EP1578432A4 (en) * 2002-10-03 2008-07-30 Epimmune Inc HLA BINDING PEPTIDES AND USES THEREOF

Also Published As

Publication number Publication date
US20100151051A1 (en) 2010-06-17
CN101688205A (zh) 2010-03-31
JP5597534B2 (ja) 2014-10-01
US8742067B2 (en) 2014-06-03
US9539306B2 (en) 2017-01-10
EP2158317B1 (en) 2018-03-28
WO2008138994A1 (en) 2008-11-20
EP2158317A1 (en) 2010-03-03
JP2010526549A (ja) 2010-08-05
ES2674710T3 (es) 2018-07-03
CA2685551C (en) 2016-11-29
CA2685551A1 (en) 2008-11-20
AU2008249961B2 (en) 2017-02-02
AU2008249961A1 (en) 2008-11-20
CN101688205B (zh) 2013-07-24
US20140134276A1 (en) 2014-05-15

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
ZA201000185B (en) 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
IL202376A (en) History of pyridazinone, drugs and their kit containing and use
IL198911A0 (en) Drug delivery
EP2361081A4 (en) MULTI-PARALLEL INTRA-ORAL DOSAGE FORM AND USE THEREOF
EP1981527A4 (en) THERMALLY TARGET DELIVERY OF DRUGS SUCH AS DOXORUBICIN
GB0803072D0 (en) Solid pharmaceutical and vaccien dose
EP2157093A4 (en) HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE
IL204442A (en) Inhibitors of atpase-0fif, medicinal preparations containing them and their use
EP2219725A4 (en) CUFFS FOR ACTIVE INJECTION
IL209421A (en) Kionoxalindone derivatives, medicines containing them and their use
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
EP2199402A4 (en) CYCLOASTRAGENOL MONOGLYCOSIDE, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
EP2010162A4 (en) COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
ZA201002307B (en) Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
ZA201000187B (en) 17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
TWI366566B (en) Tricyclic n-heteroarylcarboxamide derivatives, preparation thereof and therapeutic use thereof
PL2220047T3 (pl) Pochodne chinoliny, zawierające je kompozycje farmaceutyczne i ich zastosowanie
HK1142631A1 (en) Anti-tumor drug, medicament, composition, and use thereof
IL202474A0 (en) 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
ZA201000186B (en) 17b-cyano-19-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200518